8 July 2024
Kirkland Advises Eli Lilly on $3.2 Billion Morphic Acquisition
Advising firms
Deal team
21 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Keri Schick Norton Lead | Kirkland & Ellis | Partner | corporate | Not stated |
| Sarkis Jebejian Lead | Kirkland & Ellis | Partner | corporate | Not stated |
| Steven Choi Lead | Kirkland & Ellis | Partner | corporate | Not stated |
| Inhae Song | Kirkland & Ellis | Associate | corporate | Not stated |
| Molly Kaleya | Kirkland & Ellis | Associate | corporate | Not stated |
| Victor Simonte | Kirkland & Ellis | Associate | corporate | Not stated |
| Prince Oroke | Kirkland & Ellis | Associate | corporate | Not stated |
| Sophia Hudson | Kirkland & Ellis | Partner | capital markets | Not stated |
| Sharon Freiman | Kirkland & Ellis | Partner | capital markets | Not stated |
| Lia-Michelle Keane | Kirkland & Ellis | Associate | capital markets | Not stated |
| Soo Kyung Chae | Kirkland & Ellis | Associate | capital markets | Not stated |
| Ryan Paulish | Kirkland & Ellis | Associate | capital markets | Not stated |
| Andrea Murino | Kirkland & Ellis | Partner | antitrust & competition | Not stated |
| Samantha Morelli | Kirkland & Ellis | Partner | antitrust & competition | Not stated |
| Shellie Freedman | Kirkland & Ellis | Partner | technology & IP transactions | Not stated |
| Ben Kovach | Kirkland & Ellis | Associate | technology & IP transactions | Not stated |
| Andy White | Kirkland & Ellis | Associate | technology & IP transactions | Not stated |
| Rob Fowler | Kirkland & Ellis | Partner | executive compensation | Not stated |
| Annemarie Mierzejewski | Kirkland & Ellis | Associate | executive compensation | Not stated |
| Diana Soriano | Kirkland & Ellis | Associate | executive compensation | Not stated |
| Kate Hardey | Kirkland & Ellis | Partner | healthcare | Not stated |
Stated terms
- Stated value
- USD 3.20bn ($3.2 billion)
- What the figure measures
- Total transaction value
- Client
- Eli Lilly and CompanyBuy-side
- Counterparties
- Morphic Holding, Inc. (Sell-side)